Pharma-Backed Democrats Rally Opposition To Vaccine Patent Waiver
Huff PostDemocratic Reps. Scott Peters, left, and Ron Kind, sit on committees that regulate the pharmaceutical industry and are among the biggest recipients of industry cash. Getty Images Two House Democrats are soliciting support for a letter calling on President Joe Biden to continue denying developing countries’ request for a temporary waiver from intellectual property rules that severely limit their ability to mass produce COVID-19 vaccines developed in the United States and Europe. “While we agree with the parties’ purported objectives of expanding distribution as rapidly as possible, we believe eliminating those protections would not advance that goal and may even serve to delay global distribution of vaccines.” The draft praises Biden for refusing to grant the waiver thus far and claims that acceding to developing countries’ demands would actually jeopardize global efforts to manufacture 10 billion vaccine doses by the end of this year. “Intellectual property protections have hastened the development of new COVID vaccines and treatments in record time.” - Draft of letter being circulated by Reps. Scott Peters and Ron Kind In addition, current vaccine production capacity does not appear to be on track to meet global demand. Notwithstanding the pair’s letter, support for a temporary waiver on the WTO’s Trade-Related Aspects of Intellectual Property Rights or patent rules is growing among Democrats in Congress.